To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Already have an account?
GPCR Conference: ‘Novel Applications and Cutting Edge Technologies for GPCR Screening and Profiling’
Read time: Less than a minute
Taking place at The Nucleus conference centre, Chesterford Research Park, Saffron Walden, UK from 22 - 23 September 2009, the new scientific conference ‘Novel Applications and Cutting Edge Technologies for GPCR Screening and Profiling’ will provide delegates with the opportunity to hear from thought leaders and share experiences within this field.
Keynote speaker Fiona Marshall, Chief Scientific Officer, Heptares Therapeutics, will talk about “Structure-based Drug Discovery for GPCR Targets”.
The meeting will highlight the latest technological developments and tools available for drug discovery on GPCR receptors, with key opinion leaders presenting their experience of generating high-quality screening data.
Furthermore, case studies will be described where flexible assay formats and newly available tools have enhanced throughput for successful compound screening.
This meeting is being sponsored by three pioneering companies in GPCR research, BioFocus DPI, DiscoveRx and MDS Analytical Technologies.
Keynote speaker Fiona Marshall, Chief Scientific Officer, Heptares Therapeutics, will talk about “Structure-based Drug Discovery for GPCR Targets”.
The meeting will highlight the latest technological developments and tools available for drug discovery on GPCR receptors, with key opinion leaders presenting their experience of generating high-quality screening data.
Furthermore, case studies will be described where flexible assay formats and newly available tools have enhanced throughput for successful compound screening.
This meeting is being sponsored by three pioneering companies in GPCR research, BioFocus DPI, DiscoveRx and MDS Analytical Technologies.
